Journal of Clinical Endocrinology & Metabolism, Vol 65, 364-367, Copyright © 1987 by Endocrine Society

ARTICLES

Somatostatin does not alter insulin-mediated glucose disposal

GS Meneilly, D Elahi, KL Minaker and JW Rowe

We examined the effect of somatostatin (SRIH) infusion on insulin- mediated glucose disposal (Rd) in normal young subjects (n = 8) to determine the influence of SRIH on insulin action. Paired 3-h euglycemic insulin clamp studies were performed in random order employing insulin alone (25 mU/m2 X min) or insulin with SRIH (250 micrograms/h) and replacement of basal glucagon (0.4 ng/kg X min). Basal plasma glucose, insulin, glucagon (IRG), and GH concentrations, hepatic glucose production, and Rd were similar on each occasion. Steady state (10-180 min) plasma insulin insulin alone, 283 +/- 10 (+/- SEM); insulin, IRG, and SRIH, 284 +/- 10 pmol/L) and glucagon levels (insulin alone, 84 +/- 7; insulin, IRG, and SRIH, 82 +/- 7 ng/L) were similar. Hepatic glucose production (insulin alone, 0.66 +/- 0.12; insulin, IRG, and SRIH, 0.78 +/- 0.48 mg/kg X min) and Rd (insulin alone, 8.16 +/- 0.62; insulin, IRG, and SRIH, 8.17 +/- 0.61 mg/kg X min) were not different at steady state. We conclude that SRIH infusion with glucagon replacement does not augment insulin-mediated glucose disposal in normal young subjects at physiological insulin levels.

This article has been cited by other articles:

				N. Abate, S. M. Haffner, A. Garg, R. M. Peshock, and S. M. Grundy Sex Steroid Hormones, Upper Body Obesity, and Insulin Resistance J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4522 - 4527. [Abstract] [Full Text] [PDF]

				M. Chandalia, N. Abate, A. Garg, J. Stray-Gundersen, and S. M. Grundy Relationship between Generalized and Upper Body Obesity to Insulin Resistance in Asian Indian Men J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2329 - 2335. [Abstract] [Full Text]